MINNEAPOLIS, Jan. 19, 2012 /PRNewswire/ -- Uroplasty, Inc.
(NASDAQ: UPI) announced today that it will release financial
results for the third quarter of fiscal 2012 ended December 31, 2011, at the market close on
Thursday, January 26, 2012. The
Company will host a conference call to discuss these results on
Thursday, January 26, 2012 at
4:30 p.m. Eastern Time (3:30 p.m. Central Time). David Kaysen, President and Chief Executive
Officer, and Medi Jiwani, Vice
President, Chief Financial Officer and Treasurer, will host the
call. Individuals wishing to participate in the conference
call should dial 877-941-9205. An audio replay will be available
for 30 days following the call at 800-406-7325 (domestic) and
303-590-3030 (international), with the passcode 4502445#.
About Uroplasty, Inc.
Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned
subsidiaries in The Netherlands
and the United Kingdom, is a
medical device company that develops, manufactures and markets
innovative proprietary products for the treatment of voiding
dysfunctions. Our focus is the continued commercialization of
our Urgent PC Neuromodulation System, which we believe is the only
FDA-cleared minimally invasive, office-based neuromodulation
therapy for the treatment of overactive bladder and the associated
symptoms of urinary urgency, urinary frequency and urge
incontinence.
We also offer Macroplastique Implants, an injectable urethral
bulking agent for the treatment of adult female stress urinary
incontinence primarily due to intrinsic sphincter deficiency.
For more information on the company and its products, please
visit Uroplasty, Inc. at www.uroplasty.com.
For
Further Information:
Uroplasty,
Inc.
David
Kaysen, President and CEO, or
Medi
Jiwani, Vice President, CFO, Treasurer
952.426.6140
|
EVC
Group
Doug Sherk
(Investors), 415.652.9100
Jenifer
Kirtland (Investors), 415.568.9349
Chris Gale
(Media), 646.201.5431
|
SOURCE Uroplasty, Inc.